A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus

NCT01479881 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus

Interventions

DRUG: tacrolimus
DRUG: TMC435
DRUG: cyclosporine
DRUG: TMC435

Sponsor

Tibotec Pharmaceuticals, Ireland